Alexander Martens
Tuebingen, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Early decrease of blood myeloid-derived suppressor cells during checkpoint inhibition is a favorable biomarker in metastatic melanoma.
Journal: Journal for immunotherapy of cancer
Published: April 28, 2023
Expansion and Determination of Antigen-Reactive T Cells by Flow Cytometry.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: January 23, 2019
First-line therapy-stratified survival in BRAF-mutant melanoma: a retrospective multicenter analysis.
Journal: Cancer immunology, immunotherapy : CII
Published: August 09, 2018
Prognostic factors and treatment outcomes in 444 patients with mucosal melanoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 07, 2017
Combined treatment with ipilimumab and intratumoral interleukin-2 in pretreated patients with stage IV melanoma-safety and efficacy in a phase II study.
Journal: Cancer immunology, immunotherapy : CII
Published: September 20, 2016
Peripheral CD8 effector-memory type 1 T-cells correlate with outcome in ipilimumab-treated stage IV melanoma patients.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 14, 2016
Establishing High Dimensional Immune Signatures from Peripheral Blood via Mass Cytometry in a Discovery Cohort of Stage IV Melanoma Patients.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: May 20, 2016
Proportions of blood-borne Vδ1+ and Vδ2+ T-cells are associated with overall survival of melanoma patients treated with ipilimumab.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 01, 2016
A clinical and biological perspective of human myeloid-derived suppressor cells in cancer.
Journal: Cellular and molecular life sciences : CMLS
Published: February 04, 2016
High GDF-15 Serum Levels Independently Correlate with Poorer Overall Survival of Patients with Tumor-Free Stage III and Unresectable Stage IV Melanoma.
Journal: The Journal of investigative dermatology
Published: February 03, 2016
Increases in Absolute Lymphocytes and Circulating CD4+ and CD8+ T Cells Are Associated with Positive Clinical Outcome of Melanoma Patients Treated with Ipilimumab.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 29, 2016
Baseline Biomarkers for Outcome of Melanoma Patients Treated with Pembrolizumab.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 15, 2016
Last Updated: 09/26/2026